Latest Production Development News

Swift TV Limited has reported robust Q2 activity with over 4,300 devices pre-sold, including a significant 2,000-device order from Chevron, positioning the company for a commercial rollout in Q3 FY26.

InteliCare Holdings has advanced its aged care technology deployments and is close to appointing a new CEO, signalling a pivotal growth phase. The company also reported progress in commercial talks and product enhancements.

Nexion Group has completed the sale of its Networks businesses and is pivoting to focus on data centre operations and its FuseAI software platform, preparing for an ASX relisting.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Knosys reports steady revenue growth and a strategic partnership to upgrade its GreenOrbit platform, while accelerating development of its AI-powered Libero X library solution for a global launch next year.

Saferoads Holdings Limited reported a modest rise in quarterly sales and a half-year net profit of approximately $511k, while progressing regulatory approval for its innovative HV2 barrier.

Zeotech Limited has made significant strides in advancing its Toondoon Kaolin Project mining readiness and secured key partnerships to commercialise its AusPozz™ metakaolin product, validated by independent testing.

Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.

MONEYME has reported a robust second quarter with a 26% increase in its loan book to $1.75 billion and a 19% rise in revenue to $60 million, underpinned by improved credit quality and strategic funding initiatives.

Microba Life Sciences reports robust year-on-year growth in microbiome testing volumes and revenue, advancing towards regional break-even in Australia and the UK while progressing its therapeutic pipeline.

CurveBeam AI reported steady device orders alongside a $4 million milestone payment from its China commercialisation deal, while progressing FDA clearance and robotic surgery system validation.